# OnCo record hero (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/hero/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "hero", "NCT03085095" ;
  schema:name "HERO"@en ;
  schema:alternateName "HERO"@en, "HERO trial"@en, "relugolix against leuprolide"@en ;
  schema:description "An androgen deprivation tablet that works faster than the standard injection, wears off faster when stopped, and halved the rate of heart attacks and strokes."@en ;
  schema:url <https://onco.cc/trials/hero/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03085095>, <https://doi.org/10.1056/NEJMoa2004325>, <https://www.nice.org.uk/guidance/ta995> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mhspc/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/relugolix/>, <https://onco.cc/drugs/leuprolide/> ;
  onco:companies <https://onco.cc/companies/sumitomo-pharma/> ;
  onco:terms <https://onco.cc/terms/adt/>, <https://onco.cc/terms/hormone-therapy/>, <https://onco.cc/terms/castration-resistance/> ;
  onco:trials <https://onco.cc/trials/patch-transdermal-oestradiol/>, <https://onco.cc/trials/swog-9346/> .